PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis

Ji Liang1,2, Ruixiu Cao1,2, Yajuan Zhang1,2

  • 1Key Laboratory of Systems Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.

Nature Communications
|August 4, 2016
PubMed

Insights

Cdc25A phosphatase promotes brain tumor growth by regulating cell metabolism and pyruvate kinase M2 (PKM2) activity. Its phosphorylation at Y59 correlates with glioma malignancy and poor prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Human tumor cells frequently overexpress Cdc25A, a phosphatase regulating the cell cycle.
  • While Cdc25A's role in cell cycle regulation is known, its other substrates and functions remain largely uncharacterized.

Purpose of the Study:

  • To investigate the role of Cdc25A in tumorigenesis beyond cell cycle regulation.
  • To identify novel substrates and functions of Cdc25A in cancer, particularly in relation to EGFR signaling and cell metabolism.

Main Methods:

  • Investigated the interaction between Cdc25A, EGFR, c-Src, and pyruvate kinase M2 (PKM2).
  • Analyzed Cdc25A-mediated phosphorylation of PKM2 and its downstream effects on gene expression and cellular processes.
  • Examined human glioblastoma specimens to correlate Cdc25A Y59 phosphorylation with tumor grade and patient prognosis.

Main Results:

  • EGFR activation leads to c-Src-mediated Cdc25A phosphorylation at Y59, which then interacts with PKM2.
  • Cdc25A dephosphorylates PKM2 at S37, promoting β-catenin transactivation and c-Myc-driven expression of glycolytic genes (GLUT1, PKM2, LDHA).
  • This interaction creates a positive feedback loop, upregulating CDC25A and promoting the Warburg effect, cell proliferation, and brain tumorigenesis.

Conclusions:

  • Cdc25A plays a critical role in controlling cell metabolism, essential for EGFR-promoted tumorigenesis.
  • Cdc25A-mediated PKM2 dephosphorylation drives the Warburg effect and supports tumor growth.
  • Cdc25A Y59 phosphorylation is a potential biomarker for glioma malignancy and prognosis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K